- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05776420
Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes (VOUCH4DIABETES)
February 5, 2026 updated by: Unity Health Toronto
Effect of a Healthy Food Voucher on Blood Glucose Control in People With Type 2 Diabetes or Prediabetes: a Randomized Controlled Trial
This randomized controlled trial (RCT) will determine if access to a voucher for healthy foods reduces blood sugar levels among people living on a low income who have type 2 diabetes or elevated blood sugar.
Study Overview
Study Type
Interventional
Enrollment (Estimated)
390
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nav Persaud
- Phone Number: 416-864-6060
- Email: nav.persaud@utoronto.ca
Study Locations
-
-
-
Toronto, Canada
- Recruiting
- St Michael's Hospital Academic Family Health Team
-
Contact:
- Nav Persaud, MD
- Email: nav.persaud@utoronto.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- hemoglobin A1c 6.0 to 11.0
- report food insecurity or financial insecurity
Exclusion Criteria:
- live with a current study participant
- life expectancy < 6 months
- multiple life-threatening allergies to common foods
- require total parenteral nutrion
- blood dyscrasia that interferes with hemoglobin A1c interpretation
- hemoglobin A1c >11
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
|
|
|
Experimental: Food voucher
$65 monthly voucher for healthy foods (phase 1)
|
A voucher of that can be redeemed for food at grocery stores.
|
|
Experimental: Large voucher
$160 monthly voucher for healthy foods (phase 2)
|
A voucher of that can be redeemed for food at grocery stores.
|
|
Active Comparator: Small voucher
$40 monthly voucher for healthy foods (phase 2)
|
A voucher of that can be redeemed for food at grocery stores.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemoglobin A1c
Time Frame: 6 months
|
Change in hemoglobin A1c
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
General health ("In general, how would you rate your health today?")
Time Frame: 6 months
|
Self-reported health.
Potential responses are: very good, good, moderate, bad, very bad and decline to respond.
|
6 months
|
|
Financial security ("Do you have trouble making ends meet at the end of the month?")
Time Frame: 6 months
|
Self-reported financial security
|
6 months
|
|
Food insecurity measured by 6 questions from Household Food Security Survey
Time Frame: 6 months
|
Self-reported food insecurity
|
6 months
|
|
Fruit and vegetable consumption
Time Frame: 6 months
|
Self-reported fruit and vegetable consumption
|
6 months
|
|
Health care utilization using administrative data
Time Frame: 6 months
|
Includes hospitalizations, outpatient visits and primary care visits
|
6 months
|
|
Carotenoid level
Time Frame: 6 months
|
Serum caortenoid level
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 21, 2023
Primary Completion (Estimated)
April 1, 2027
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
February 3, 2023
First Submitted That Met QC Criteria
March 16, 2023
First Posted (Actual)
March 20, 2023
Study Record Updates
Last Update Posted (Actual)
February 10, 2026
Last Update Submitted That Met QC Criteria
February 5, 2026
Last Verified
February 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
We plan to share de-identified individual participant data
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabete Type 2
-
Medanta, The Medicity, IndiaCompletedDiabete Mellitus | Diabete Type 2 | Hyperglycaemia (Diabetic)India
-
Hospices Civils de LyonCompletedDiabete Type 2 | Diabete Type 1France
-
Rio Grande do Sul State Health Department - SES/RSAgnes Nogueira Gossenheimer; Ana Paula Rigo; Roberto Eduardo SchneidersNot yet recruitingTelemedicine | Diabete Mellitus | Diabete Type 2 | TelehealthBrazil
-
Universita di VeronaUniversity of Verona, ItalyRecruiting
-
Chong Kun Dang PharmaceuticalNot yet recruiting
-
Mapi Pharma Ltd.Not yet recruiting
-
Shanghai Yinnuo Pharmaceutical Technology Co.,...Not yet recruitingDiabete Type 2Brazil
-
China Medical University HospitalChina Medical University, TaiwanRecruiting
-
Komfo Anokye Teaching HospitalCompleted
-
Sharda UniversityRecruiting
Clinical Trials on Food voucher
-
International Food Policy Research InstituteWorld Food ProgramCompletedFood Security
-
Sutter HealthEnrolling by invitation
-
Africa Health Research InstituteLondon School of Hygiene and Tropical Medicine; University College, London; University... and other collaboratorsRecruiting
-
Cornell UniversityAfrica Future FoundationCompletedMalnutrition | Growth | Stunted Growth | Feeding, ComplementaryEthiopia
-
University of California, San DiegoUnited States Department of Agriculture (USDA); Rady Children's Hospital, San...RecruitingType 2 DiabetesUnited States
-
University of California, San FranciscoPatient-Centered Outcomes Research Institute; Agency for Healthcare Research...CompletedFood Insecurity | Kidney TransplantUnited States
-
International Food Policy Research InstituteUnited Nations World Food Programme (WFP); Addis Ababa UniversityCompletedMalnutrition | Diet; DeficiencyEthiopia
-
Stanford UniversityUniversity of California, San FranciscoCompletedCardiovascular DiseasesUnited States
-
Columbia UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Drinking | Driving DrunkUnited States
-
University of California, San FranciscoNational Institute of Mental Health (NIMH); University of California, Berkeley and other collaboratorsCompleted